We are tackling one of the most challenging and pressing problems facing humanity today - thousands of diseases have no cure.
Using our AI tools and biomedical knowledge graph, we identified an approved drug that could potentially inhibit the viral progression and the body’s inflammatory response to the novel coronavirus.find out more
It is well documented that the lack of diversity is a serious issue and immediate action is required. Our data diversity initiative exists to provide a forum to people who want to bring actionable solutions to help create a more inclusive world where no patient is left behind.
Leading edge research by Benevolent scientists and engineers has been recognised in top journals including Nature, The Lancet, and The British Medical Journal.